• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Cell Transformation, Neoplastic

Cell Transformation, Neoplastic - 8 Studies Found

Completed : Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
:
  • Leukemia
  • Lymphoma

: 2012-01-26
:
  • Genetic: gene expression analysis
  • Other: l

Active, not recruiting : Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
: Neuroblastoma
: 2007-02-15
:
  • Genetic: gene mapping
  • Genetic: polymorphis

Terminated : Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
:
  • Non-melanomatous Skin Cancer
  • Pancreatic Cancer
  • Small Intes
    : 2009-05-09
    :
    • Genetic: in situ hybridization

Completed : Biomarkers in Tissue Samples From Young Patients With Liver Cancer
:
  • Childhood Hepatoblastoma
  • Stage I Childhood Liver Cancer
  • St
    : 2011-04-15
    :
    • Genetic: RNA analysis
    • Genetic: gene expres

Active, not recruiting : Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
:
  • Adult Solid Neoplasm
  • Hormone-Resistant Prostate Cancer
  • Rec
    : 2011-11-23
    :
    • Drug: Akt Inhibitor MK2206 Giv

Completed : Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
: Leukemia
: 2007-10-22
:
  • Biological: GM-CSF Dosing sche

Active, not recruiting : A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients
: Chronic Myelogenous Leukemia
: 2015-07-26
: Drug: Flumatinib mesylate tablet 600 mg qd Flumatinib mesylate tablet 600 mg qd in CML-AP or CML-BP pati
Completed : Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
:
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • Untreated Adult Acute Myeloid Leukemia

  • : 2012-09-11
    : Drug: Nilotinib+AD induction • Post-remission consol
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.